PORTLAND, Ore. ( KOIN ) – Washington State Attorney General Bob Ferguson is partnering with five other states in a federal lawsuit against Regeneron Pharmaceuticals — alleging the company inflated Medicaid prices for a critical eye medication.
Attorney General Ferguson’s office announced the partnership on Friday, claiming the New York-based company increased the price it charged Medicaid for Eylea, which ended up costing state Medicaid programs millions of dollars for the medication.
“We’re fighting corporate greed in order to protect public health care dollars and improve the affordability of medications,” Ferguson said. “This is how we protect Medicaid dollars that allow us to provide access to health care for nearly two million Washingtonians, including children and the most vulnerable.”
Oregon coast state park reopening includes a ‘noticeable change’
Between 2013 and 2023, Medicaid programs in Washington, Colorado, Texas, Georgia, North Carolina, and Michigan collectively spent more than $175 million on Eylea, an FDA-approved medication made by Regeneron to treat macular degeneration and other eye conditions, Ferguson’s office said.